GEN Exclusives

More »

GEN News Highlights

More »
Feb 7, 2007

Multibillion-Dollar Depression Market Gets Crowded

  • With the expiration of Teva Pharmaceuticals’ 180-day market exclusivity on its generic version of Pfizer’s blockbuster depression drug, four companies are ready to enter this multibillion-dollar market.

    Zoloft, indicated for depression and certain types of anxiety disorders, had U.S. sales of approximately $2.9 billion for the 12-month period ending Dec. 31, 2006, according to IMS Health. In 2005, Pfizer’s last full year on the market, sales reached $3.5 billion.

    Mylan Pharmaceuticals, Pliva, Actavis Group, and Lupin Pharmaceuticals each received approval for sertraline hydrochloride tablets, 25 mg, 50 mg, and 100 mg.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »